- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02237287
Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers
Combination of Taliderm® and VAC for Treatment of Pressure Ulcers - a Pilot Study
Background: The wound healing promoting effect of negative wound pressure therapies (NWPT) takes place at the wound foam interface. Implementation of bioactive substances at this site represents a major research area for the development of future NWPT devices.
Methods: Wound healing kinetics of pressure ulcers treated by vacuum assisted closure devices with or without the implementation of a thin interface of poly-N-acetyl glucosamine nanofibers (sNAG) was studied in a prospective randomized clinical trial.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Basel, Switzerland, 4031
- University Hospital Basel
-
Nottwil, Switzerland, 6207
- Swiss Paraplegic Centre Nottwil
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ischial/sacral Pressure ulcer between 4 and 15cm diameter
- Greater than or equal to 18 years of age
- Ability to obtain informed consent
Exclusion Criteria:
- Connective tissue disorders
- Immunosuppression, Hemodialysis, Steroids
- Pregnancy
- Sepsis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
SHAM_COMPARATOR: wound dressing with VAC
After wound debridement wounds are treated for 2 weeks with VAC dressing alone
|
|
OTHER: wound dressing with VAC and sNAG under Antiaggregation
In patients being under antiaggregation with Aspirin® 100mg daily, after wound debridement wounds are treated with VAC and sNAG
|
|
EXPERIMENTAL: wound dressing with VAC and sNAG without antiaggregation
In patients NOT being under antiaggregation, after wound debridement wounds are treated with VAC and sNAG
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time Frame: up to 1 year
|
up to 1 year
|
Wound surface area increase, respectively decrease as a measure of the effect of the studied devices on pressure ulcer healing
Time Frame: up to 1 year
|
up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wound Healing characteristics
Time Frame: up to 1 year
|
Evaluation of granulation tissue formation in study groups
|
up to 1 year
|
Wound Healing characteristics
Time Frame: up to 1 year
|
Evaluation of wound epithelialization in study groups
|
up to 1 year
|
Wound Healing characteristics
Time Frame: up to 1 year
|
Evaluation of wound contraction in study groups
|
up to 1 year
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Dirk J. Schaefer, Prof.Dr., University Hospital, Basel, Switzerland
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-MD-0007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcer
-
The Cleveland ClinicRecruitingStage 1 Pressure Ulcer | Stage 2 Pressure UlcerUnited States, Austria
-
University GhentCare of Sweden ABCompletedPressure Ulcer | Pressure Injury | Pressure Ulcer, Buttock | Pressure SoreBelgium
-
Integra LifeSciences CorporationSt Vincent's HospitalCompletedPressure Ulcer | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Our Lady of Maryknoll HospitalWong Tai Sin HospitalUnknownPressure Ulcers Stage III | Pressure Ulcer, Stage IVHong Kong
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Bayside HealthCompletedLength of ICU Stay | Pressure Ulcer, Area | Pressure Ulcer, Grade | Albumin Level | Risk ScoreAustralia
-
University of PittsburghUnited States Department of Defense; Georgia Institute of TechnologyCompletedPressure Ulcer | Pressure Injury | Pressure Ulcer, ButtockUnited States
-
Istanbul Medipol University HospitalCompletedPressure Ulcers Stage III | Pressure Ulcer, Stage IV
-
Istituto Ortopedico RizzoliCompleted
-
Yonsei UniversityUnknownPostoperative Pressure Ulcer
Clinical Trials on wound dressing with VAC
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
University of Alabama at Birmingham3MCompletedOrthopaedic Traumatic Open FracturesUnited States
-
University of MichiganRecruitingSpine Surgery | Wounds VacUnited States
-
San Antonio Military Medical CenterUnknownOpen Abdomen After Damage Control LaparotomyUnited States
-
Mayo Clinic3MCompletedSurgical Wound InfectionUnited States
-
The University of Texas Health Science Center at...TerminatedCompartment Syndromes | WoundsUnited States
-
University of Alabama at Birmingham3MCompletedFracture of Calcaneus, Pilon or Tibial PlateauUnited States
-
Kerecis Ltd.CompletedPunch Biopsy Wounds | Healing TimesIceland
-
Yale UniversityWithdrawnAbdominal ReconstructionUnited States
-
Coloplast A/SRecruitingPartial-thickness BurnUnited Kingdom